NXGL
NEXGEL, INC.Company Information
- Company Name
- NEXGEL, INC.
- CIK
- CIK0001468929
- Category
- <br>Emerging growth company
- Ticker: Exchange
- NXGL: Nasdaq, NXGLW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- NXGL
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-11-20
- Last sale
- 2026-06-23
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 47,272
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 439,415
- Shares outstanding
- 9,013,261
- Ownership
- 4.88%
Earnings Market Reaction
- Filing date
- 2026-08-17
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 3 | 3 | ||||||
| Restricted Cash | 1 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Restricted Cash Current | 1 | 2 | 1 | 1 | - | - | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Inventory Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 6 | 6 | 4 | 6 | 4 | 5 | 5 | 5 | 4 | 5 | 5 | 6 | ||||||
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 13 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | ||||||
| Operating Lease Right Of Use Asset | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Investments | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 26 | 12 | 10 | 12 | 10 | 10 | 11 | 11 | 10 | 10 | 10 | 10 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | - | - | - | - | - | - | - | 2 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Accrued Liabilities And Other Liabilities | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Business Combination Contingent Consideration Liability | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Operating Lease Liability Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Derivative Liabilities Current | 9 | - | - | - | 0 | 0 | - | - | - | - | - | - | ||||||
| Liabilities Current | 14 | 3 | 3 | 3 | 2 | 3 | 2 | 3 | 3 | 2 | 3 | 2 | ||||||
| Operating Lease Liability Noncurrent | 3 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Convertible Long Term Notes Payable | - | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
| Long Term Loans Payable | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Convertible Debt Noncurrent | 3 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Long Term Notes Payable | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Liabilities | 21 | 7 | 6 | 6 | 5 | 5 | 5 | 6 | 5 | 5 | 5 | 4 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 30 | 26 | 25 | 25 | 24 | 24 | 24 | 22 | 21 | 20 | 19 | 19 | ||||||
| Retained Earnings Accumulated Deficit | -26 | -22 | -21 | -20 | -19 | -19 | -18 | -17 | -16 | -16 | -15 | -14 | ||||||
| Stockholders Equity | 5 | 4 | 5 | 5 | 5 | 5 | 6 | 5 | 4 | 5 | 5 | 6 | ||||||
| Minority Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Liabilities And Stockholders Equity | 26 | 12 | 10 | 12 | 10 | 10 | 11 | 11 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Common Stock Shares Issued | 10 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 6 | 6 | 6 | 6 | ||||||
| Shares Outstanding | 10 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 6 | 6 | 6 | 6 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNEXGEL, INC. (NXGL) — SEC Financial Statements & Analysis
NEXGEL, INC. (NXGL) is a surgical & medical instruments & apparatus company, incorporated in DE. NEXGEL, INC. trades on Nasdaq as: NXGL, NXGLW. NEXGEL, INC. (NXGL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-17. Based on that filing, NEXGEL, INC. carries a market cap of $4.52M, a P/E ratio of -0.72x, a P/B ratio of 0.83x, a P/S ratio of 0.37x, an enterprise value of $7.89M, and an EV/EBITDA multiple of -1.86x. On profitability, it posts a gross margin of 35.08%, an operating margin of -44.77%, a net margin of -51.74%, a Return on Equity (ROE) of -118.70%, a Return on Assets (ROA) of -34.54%, and a Return on Invested Capital (ROIC) of -73.91%. Per share, it reports EPS of $-0.69, diluted EPS of $-0.69, free cash flow per share of $-1.08, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 3.38% year-over-year, net income growth of 118.25% year-over-year, and EPS growth of 85.34% year-over-year. On the balance sheet, it maintains a current ratio of 0.43x, a quick ratio of 0.19x, working capital of $-8.27M, a debt-to-equity ratio of 3.84x, a debt ratio of 0.79, an interest coverage ratio of -2.37x, free cash flow of $-9.72M (TTM), and net debt of $3.37M. Figures sourced from SEC EDGAR.
- Market Cap
- $4.52M
- P/E TTM
- -0.72x
- EPS TTM
- $-0.69
- P/B TTM
- 0.83x
- ROE TTM
- -118.70%
- ROA TTM
- -34.54%
- Debt To Equity
- 3.84x
- Free Cash Flow TTM
- $-9.72M
- Net Revenue TTM Growth 1Y
- 3.38%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NEXGEL, INC. in?
NEXGEL, INC. (NXGL) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does NXGL trade on?
NEXGEL, INC. (NXGL) trades on the Nasdaq.
Where is NEXGEL, INC. incorporated?
NEXGEL, INC. is incorporated in DE.
When was NEXGEL, INC. (NXGL)'s most recent SEC filing?
NEXGEL, INC. (NXGL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-17.
What is NXGL's market cap?
NEXGEL, INC. (NXGL) has a market capitalization of $4.52M as of 2026-06-30.
What is NXGL's EPS (earnings per share)?
NEXGEL, INC. (NXGL)'s trailing twelve month EPS is $-0.69 as of 2026-06-30.
What is NXGL's ROE (return on equity)?
NEXGEL, INC. (NXGL)'s trailing twelve month Return on Equity (ROE) is -118.70% as of 2026-06-30.
What is NXGL's ROA (return on assets)?
NEXGEL, INC. (NXGL)'s trailing twelve month Return on Assets (ROA) is -34.54% as of 2026-06-30.
What is NXGL's ROIC (return on invested capital)?
NEXGEL, INC. (NXGL)'s trailing twelve month Return on Invested Capital (ROIC) is -73.91% as of 2026-06-30.
What is NXGL's EV/EBITDA?
NEXGEL, INC. (NXGL)'s trailing twelve month EV/EBITDA is -1.86x as of 2026-06-30.